Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1433-1435
doi: 10.1161/01.CIR.0000033634.60453.22
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weyrich, A. S.
Right arrow Articles by Zimmerman, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weyrich, A. S.
Right arrow Articles by Zimmerman, G. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Restenosis
Right arrow Cell biology/structural biology
Right arrowRelated Article

(Circulation. 2002;106:1433.)
© 2002 American Heart Association, Inc.

Platelets, Endothelial Cells, Inflammatory Chemokines, and Restenosis

Complex Signaling in the Vascular Play Book

Andrew S. Weyrich, PhD; Stephen M. Prescott, MD; Guy A. Zimmerman, MD

From the Department of Internal Medicine (A.S.W., S.M.P., G.A.Z.), The Huntsman Cancer Institute (S.M.P.), and The Program in Human Molecular Biology and Genetics (A.S.W., G.A.Z.), The University of Utah, Salt Lake City.

Correspondence to Guy Zimmerman, Program in Human Molecular Biology and Genetics, Eccles Institute of Human Genetics, 15 N 2030 East, Bldg. 533, Rm. 4220, University of Utah, Salt Lake City, UT 84112. E-mail guy.zimmerman@hmbg.utah.edu


Key Words: Editorials • endothelium • platelets • leukocytes • inflammation


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Adhesive and signaling interactions between endothelial cells and leukocytes are key mechanisms that mediate both targeting of the blood cells to specific sites and information transfer that results in change in their phenotypes and function.1 These events are beneficial in defense against microbes and wound surveillance and repair; however, in dysregulated inflammatory conditions such as atherosclerosis and its complications, including acute coronary syndromes and restenosis after interventional procedures, accumulation and activation of leukocytes can injure the host. The cell–cell interactions and signaling mechanisms are complex in the game of inflammation, and there are a number of players. In addition to endothelial cells and leukocytes, platelets contribute to leukocyte accumulation and to changes in their behavior in both physiological and pathological conditions,2,3,4 emphasizing the intimate relationship between the thrombotic and inflammatory systems.

See p 1523

One mechanism involves direct adhesion of activated platelets to monocytes, neutrophils, or other leukocyte subclasses and binding of chemokines or lipid signaling molecules that are released from the platelets or displayed in a juxtacrine fashion on their surfaces (see below), to receptors on the leukocyte plasma membrane.3,5 In this issue of Circulation, Schober and co-workers6 report a different play in the inflammatory repertoire: platelets interacting with inflamed endothelial cells donate the CC chemokine regulated upon activation normal T cell expressed presumed secreted (RANTES) to the endothelial surface, where it acts as a cell-associated signal for adhesion of monocytes. A number of the observations were made with cultured endothelial monolayers, incubated under conditions of stasis or . . . [Full Text of this Article]


Related Article:

Deposition of Platelet RANTES Triggering Monocyte Recruitment Requires P-Selectin and Is Involved in Neointima Formation After Arterial Injury
Andreas Schober, David Manka, Philipp von Hundelshausen, Yuqing Huo, Peter Hanrath, Ian J. Sarembock, Klaus Ley, and Christian Weber
Circulation 2002 106: 1523-1529. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. O'Donoghue, E. M. Antman, E. Braunwald, S. A. Murphy, P. G. Steg, A. Finkelstein, W. F. Penny, V. Fridrich, C. H. McCabe, M. S. Sabatine, et al.
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) Analysis.
J. Am. Coll. Cardiol., August 18, 2009; 54(8): 678 - 685.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. de la Motte, J. Nigro, A. Vasanji, H. Rho, S. Kessler, S. Bandyopadhyay, S. Danese, C. Fiocchi, and R. Stern
Platelet-Derived Hyaluronidase 2 Cleaves Hyaluronan into Fragments that Trigger Monocyte-Mediated Production of Proinflammatory Cytokines
Am. J. Pathol., June 1, 2009; 174(6): 2254 - 2264.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
B. B. Dokken
The Pathophysiology of Cardiovascular Disease and Diabetes: Beyond Blood Pressure and Lipids
Diabetes Spectr, July 1, 2008; 21(3): 160 - 165.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Danese, E. Dejana, and C. Fiocchi
Immune Regulation by Microvascular Endothelial Cells: Directing Innate and Adaptive Immunity, Coagulation, and Inflammation
J. Immunol., May 15, 2007; 178(10): 6017 - 6022.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. S. Sabatine, C. P. Cannon, C. M. Gibson, J. L. Lopez-Sendon, G. Montalescot, P. Theroux, B. S. Lewis, S. A. Murphy, C. H. McCabe, E. Braunwald, et al.
Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics: The PCI-CLARITY Study
JAMA, September 14, 2005; 294(10): 1224 - 1232.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Simeoni, B. R. Winkelmann, M. M. Hoffmann, S. Fleury, J. Ruiz, L. Kappenberger, W. Marz, and G. Vassalli
Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis
Eur. Heart J., August 2, 2004; 25(16): 1438 - 1446.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Kalvegren, M. Majeed, and T. Bengtsson
Chlamydia pneumoniae Binds to Platelets and Triggers P-Selectin Expression and Aggregation: A Causal Role in Cardiovascular Disease?
Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1677 - 1683.
[Abstract] [Full Text] [PDF]